Skip to content
★ Sign in to follow
RM

Ronald M. Kurtz MD

Autre
Total declarations
12
Company
1
▲ Purchases (2 ops.)
€1.7M
▼ Sales (6 ops.)
€7.1M

Latest filing published 09 Aug 2024 for RxSight, Inc., €106k.

Filing timeline

BuySale
Ronald M. Kurtz MD

Insider track record

Disclosed buys
2
Disclosed sells
6
T+90 hit rate
100%
T+90 mean return
+7.3%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Ronald M. Kurtz MD: trading record in brief

Ronald M. Kurtz MD is a declared insider of RxSight, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 3 August 2021 to 9 August 2024, the count stands at 12 filings.

Market trades split into 2 purchases (€1.7M) and 6 sales (€7.1M). On balance, insiders were net sellers of €5.3M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant and 3 option exercises. 2024 to date brings no purchases and 3 sales.

The record was last updated on 9 August 2024 with an option exercise (€9,145) in RxSight, Inc. The latest purchase dates back some time: it was published 1,922 days ago, on 5 August 2021. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Ronald M. Kurtz MD

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ◇
    President & CEOExecutivesRxSight, Inc.
    115,376 USD36SEC
    7,650 shares@ US$15.08181.2% of flowCommon StockSEC:0000950170-24-094918:0
  • ◇
    President & CEOExecutivesRxSight, Inc.
    203,604 USD36SEC
    13,500 shares@ US$15.08182.0% of flowCommon StockSEC:0000950170-24-083334:0
  • ▼
    President & CEOExecutivesRxSight, Inc.
    2M USD38SEC
    40,000 shares@ US$60.146824.4% of flowCommon StockSEC:0000950170-24-053667:0
  • ▼
    President & CEOExecutivesRxSight, Inc.
    1M USD59SEC
    31,250 shares@ US$43.5013.5% of flowCommon StockSEC:0000950170-24-003332:0
  • ▼
    President & CEOExecutivesRxSight, Inc.
    924,498 USD59SEC
    22,500 shares@ US$41.08889.1% of flowCommon StockSEC:0001209191-23-060012:0
  • ▼
    President & CEOExecutivesRxSight, Inc.
    800,164 USD59SEC
    20,000 shares@ US$40.00828.0% of flowCommon StockSEC:0001209191-23-059039:0
  • ◆
    President & CEOExecutivesRxSight, Inc.
    500,000 USD41SEC
    40,000 shares@ US$12.505.1% of flowCommon StockSEC:0001209191-23-008846:0
  • ▲
    See RemarksExecutivesRxSight, Inc.
    2M USD26SEC
    125,000 shares@ US$16.0022.5% of flowCommon StockSEC:0000899243-21-031814:0
    Canonical exit: 1 Nov 2021 (T+90)

8 of 8 declarations